Researchers Fail to Reveal Full Drug Pay

For years big pharma has subsidized research and that was a common practice for many years, and I’m sure these are not the only folks being looked at. Failure to disclose is perhaps another matter. In the world of transparency we live in today, many things are changing, including the way clinical studies are conducted and funded. In a recent post yesterday about the Hughes Medical Foundation, breakthroughs are coming rapidly as they do not have to withstand the red tape of a 300 pages report to be sent to the National Institute of Health to obtain a grant. Personal funding today is playing more of an important role than it ever has. Before scrutinizing too far, perhaps it’s best to take a look back and see what the results were from the outcomes of the sponsored studies.

With the evolving world of personalized medicine, pharma may not be in the driver’s seat for too much longer and the world is changing around us. This will be an interesting case to see what direction the story turns next. BD

A world-renowned Harvard child psychiatrist whose work has helped fuel an explosion in the use of powerful antipsychotic medicines in children earned at least $1.6 million in consulting fees from drug makers from 2000 to 2007 but for years did not report much of this income to university officials, according to information given Congressional investigators.

Researchers Fail to Reveal Full Drug Pay - NYTimes.com